<code id='C18C14D23C'></code><style id='C18C14D23C'></style>
    • <acronym id='C18C14D23C'></acronym>
      <center id='C18C14D23C'><center id='C18C14D23C'><tfoot id='C18C14D23C'></tfoot></center><abbr id='C18C14D23C'><dir id='C18C14D23C'><tfoot id='C18C14D23C'></tfoot><noframes id='C18C14D23C'>

    • <optgroup id='C18C14D23C'><strike id='C18C14D23C'><sup id='C18C14D23C'></sup></strike><code id='C18C14D23C'></code></optgroup>
        1. <b id='C18C14D23C'><label id='C18C14D23C'><select id='C18C14D23C'><dt id='C18C14D23C'><span id='C18C14D23C'></span></dt></select></label></b><u id='C18C14D23C'></u>
          <i id='C18C14D23C'><strike id='C18C14D23C'><tt id='C18C14D23C'><pre id='C18C14D23C'></pre></tt></strike></i>

          entertainment

          entertainment

          author:focus    Page View:377
          STAT

          What if CRISPR isn’t all that commercial? How does the NurOwn story end? And how do you pronounce “Bayer”?

          We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. Live from Boston at the 2023 STAT Summit, we discuss the latest news in the life sciences, including a milestone in genome editing, a twist in the search for ALS treatments, and the polarizing process of saying words in biotech.

          advertisement

          For more on what we cover, here’s the latest from the Summit; here’s where you can find episodes of Color Code; and here’s where you can subscribe to the First Opinion Podcast.

          Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

          And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

          advertisement

          focus

          The cancer drug shortage isn’t new — and neither are the solutions
          The cancer drug shortage isn’t new — and neither are the solutions

          PreparingachemotherapytreatmentatDukeCancerCenterinDurham,N.C.GerryBroome/APAyounggirl,maybe5or6year

          read more
          Generate Biomedicines machine learning biotech raises $273M
          Generate Biomedicines machine learning biotech raises $273M

          AdobeBiotechstartupGenerateBiomedicines,whichusesartificialintelligencetofindnewdrugs,raised$273mill

          read more
          Duchenne breakthrough therapy leaves behind pioneering families
          Duchenne breakthrough therapy leaves behind pioneering families

          DuchennemusculardystrophyDr.EdwinP.Ewing,Jr./CDCPatFurlongwassittinginherhomeofficeinMiddletown,Ohio

          read more

          New weight loss drugs vying to be the next Wegovy or Mounjaro

          MollyFergusonforSTATTheexplodingpopularityofdrugslikeWegovyandMounjarohaspropelleddozensofcompaniest